HLS THERAPEUTICS INC (HLS.CA) Stock Analyst Ratings
Canada - Toronto Stock Exchange - TSX:HLS - CA40390B1094 - Common Stock
4.68 CAD
+0.12 (+2.63%)
ChartMill assigns a Buy % Consensus number of 80% to HLS.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 7.75. This target is 65.64% above the current price.
- HLS.CA was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about HLS.CA.
- In the previous month the buy percentage consensus was at a similar level.
- HLS.CA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-11 | Stifel Nicolaus Research | Downgrade | |
| 2022-10-26 | Stifel Nicolaus Research | Maintains | Buy |
| 2022-08-25 | Raymond James Capital | Downgrade | Outperform |
| 2022-08-12 | Stifel Nicolaus Research | Downgrade | |
| 2022-05-06 | Raymond James Capital | Initiate | Outperform |
| 2022-04-27 | Clarus Securities | Reiterate | Buy |
| 2022-04-27 | Raymond James Capital | Upgrade | Outperform |
| 2022-03-21 | Clarus | Initiate | Buy |
| 2022-03-20 | Raymond James Capital | Initiate | Outperform |
| 2022-03-20 | Canaccord Capital | Downgrade | Buy |
| 2022-03-15 | Raymond James Capital | Initiate | Outperform |
| 2022-03-10 | Stifel Nicolaus Research | Initiate | Buy |
| 2021-12-16 | Raymond James Financial | Initiate | Outperform |
| 2021-11-05 | RJ Financial | Initiate | Outperform |
| 2021-10-28 | Raymond James Financial | Initiate | Outperform |
| 2021-08-17 | Raymond James Financial | Upgrade | Outperform |
HLS THERAPEUTICS INC / HLS.CA FAQ
What do analysts expect the price target to be for HLS THERAPEUTICS INC (HLS.CA)?
8 analysts have analysed HLS.CA and the average price target is 7.75 CAD. This implies a price increase of 65.64% is expected in the next year compared to the current price of 4.68.
What is the consensus rating for HLS stock?
The consensus rating for HLS THERAPEUTICS INC (HLS.CA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.